#GoASCO20 OR #ASCO20 until:2020-05-30, Twitter, 6/2/2020 5:21:58 PM, 228690


FAQ | Problem?

#GoASCO20 OR #ASCO20 until:2020-05-30 Twitter NodeXL SNA Map and Report for Tuesday, 02 June 2020 at
#GoASCO20 OR #ASCO20 until:2020-05-30 Twitter NodeXL SNA Map and Report for Tuesday, 02 June 2020 at
From:
scotpublichealth
Uploaded on:
June 02, 2020
Short Description:
#GoASCO20 OR #ASCO20 until:2020-05-30 via NodeXL https://bit.ly/2XX2ino
@asco
@crisbergerot
@oncoalert
@marklewismd
@tmprowell
@glopesmd
@narjustdumamd
@conquercancerfd
@thelancet
@chrislancashir3

Top hashtags:
#asco20
#lcsm
#cancer
#covid19
#oncoalert
#askreuters

Description:
Description
The graph represents a network of 5,821 Twitter users whose recent tweets contained "#GoASCO20 OR #ASCO20 until:2020-05-30", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Tuesday, 02 June 2020 at 07:11 UTC.

The tweets in the network were tweeted over the 3-day, 6-hour, 18-minute period from Tuesday, 26 May 2020 at 17:41 UTC to Friday, 29 May 2020 at 23:59 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 5821
Unique Edges : 23125
Edges With Duplicates : 27875
Total Edges : 51000
Self-Loops : 2397
Reciprocated Vertex Pair Ratio : 0.0782624906785981
Reciprocated Edge Ratio : 0.145164078979218
Connected Components : 244
Single-Vertex Connected Components : 150
Maximum Vertices in a Connected Component : 5362
Maximum Edges in a Connected Component : 50386
Maximum Geodesic Distance (Diameter) : 10
Average Geodesic Distance : 3.445211
Graph Density : 0.000853616276179799
Modularity : 0.31293
NodeXL Version : 1.0.1.433
Data Import : The graph represents a network of 5,821 Twitter users whose recent tweets contained "#GoASCO20 OR #ASCO20 until:2020-05-30", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Tuesday, 02 June 2020 at 07:11 UTC.

The tweets in the network were tweeted over the 3-day, 6-hour, 18-minute period from Tuesday, 26 May 2020 at 17:41 UTC to Friday, 29 May 2020 at 23:59 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

Layout Algorithm : The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.
Graph Source : TwitterSearch
Graph Term : #GoASCO20 OR #ASCO20 until:2020-05-30
Groups : The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.
Edge Color : Edge Weight
Edge Width : Edge Weight
Edge Alpha : Edge Weight
Vertex Radius : Followers
Vertex Alpha : Followers

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[61] https://meetinglibrary.asco.org/results?meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[56] https://meetinglibrary.asco.org/results;page=0?filters=JTVCJTdCJTIyZmllbGQlMjIlM0ElMjJNZWRpYVR5cGVzJTIyJTJDJTIydmFsdWUlMjIlM0ElMjJBYnN0cmFjdHMlMjIlMkMlMjJxdWVyeVZhbHVlJTIyJTNBJTIyQWJzdHJhY3RzJTIyJTJDJTIyY2hpbGRyZW4lMjIlM0ElNUIlNUQlN0QlNUQ%3D&meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[48] https://ccc19.org/
[42] https://twitter.com/ASCO/status/1265251595413000192
[34] https://meetinglibrary.asco.org/browse-meetings/2020%20ASCO%20Virtual%20Scientific%20Program
[29] https://twitter.com/ASCOPres/status/1265727063144697858
[28] https://www.conquer.org/news/conquer-cancer-grants-more-8-million-cancer-research?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[27] https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931187-9%2Ffulltext&rc=0
[26] https://www.statnews.com/2020/05/28/astrazeneca-study-results-could-change-treatment-for-certain-early-stage-lung-cancer-patients/
[26] https://meetinglibrary.asco.org/user/login?destination=/node/69066

Top URLs in Tweet in G1:
[48] https://ccc19.org/
[20] https://twitter.com/ASCO/status/1265251595413000192
[19] https://twitter.com/ASCOPres/status/1265727063144697858
[18] http://www.CONQUER.ORG/Together?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[17] https://www.conquer.org/news/conquer-cancer-grants-more-8-million-cancer-research?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[15] https://meetinglibrary.asco.org/user/login?destination=/node/69066
[13] https://meetinglibrary.asco.org/results?meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[13] https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931187-9%2Ffulltext&rc=0
[12] https://www.onclive.com/conference-coverage/asco-2020/asco-2020-top-kols-select-vital-studies-ahead-of-virtual-meeting
[11] http://meetings.asco.org/am/

Top URLs in Tweet in G2:
[25] https://meetinglibrary.asco.org/results;page=0?filters=JTVCJTdCJTIyZmllbGQlMjIlM0ElMjJNZWRpYVR5cGVzJTIyJTJDJTIydmFsdWUlMjIlM0ElMjJBYnN0cmFjdHMlMjIlMkMlMjJxdWVyeVZhbHVlJTIyJTNBJTIyQWJzdHJhY3RzJTIyJTJDJTIyY2hpbGRyZW4lMjIlM0ElNUIlNUQlN0QlNUQ%3D&meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[19] https://meetinglibrary.asco.org/results?meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[16] https://www.statnews.com/2020/05/28/astrazeneca-study-results-could-change-treatment-for-certain-early-stage-lung-cancer-patients/
[5] https://www.conquer.org/news/conquer-cancer-grants-more-8-million-cancer-research?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[5] https://meetinglibrary.asco.org/record/185083/video
[4] https://www.amgenoncology.com/
[4] https://meetinglibrary.asco.org/record/186629/abstract
[4] https://oncologypressroom-ljcom.fr
[4] https://meetings.asco.org/am/virtual-format
[3] https://meetinglibrary.asco.org/user/login?destination=/node/69066

Top URLs in Tweet in G3:
[15] https://meetinglibrary.asco.org/results?meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[13] https://twitter.com/ASCO/status/1265251595413000192
[7] https://meetinglibrary.asco.org/browse-meetings/2020%20ASCO%20Virtual%20Scientific%20Program
[7] https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931187-9%2Ffulltext&rc=0
[7] https://www.practiceupdate.com/content/asco-2020-abstract-recommendations-from-dr-eric-jonasch-for-renal-cell-carcinoma/100990/13/10/3?usersourceid=2287
[6] https://meetings.asco.org/am/frequently-asked-questions-faqs
[6] https://meetinglibrary.asco.org/user/login?destination=/node/69066
[6] https://www.practiceupdate.com/c/101279/48/1
[6] https://oncology.medicinematters.com/asco-2020/coverage/18012822
[5] http://www.CONQUER.ORG/Together?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter

Top URLs in Tweet in G4:
[19] https://meetinglibrary.asco.org/browse-meetings/2020%20ASCO%20Virtual%20Scientific%20Program
[11] https://ir.trilliumtherapeutics.com/press-releases/press-release-details/2020/Trillium-Therapeutics-Provides-Update-on-the-Phase-I--Dose-Escalation-Study-of-Its-CD47-Blocker-TTI-622--at-the-ASCO20-Virtual-Scientific-Program/default.aspx
[9] https://www.youtube.com/watch?v=OunElN6v3yg&feature=youtu.be

[8] https://meetinglibrary.asco.org/results?meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[7] https://www.adaptimmune.com/investors-and-media/news-events/press-releases/detail/172/spear-t-cells-targeting-mage-a4-demonstrate-new-responses
[7] https://javatar.bluematrix.com/docs/pdf/0ab91fe0-5e9b-47d4-9d7d-3a993f52f0c9.pdf
[7] https://www.ampbioresearch.com/biopharma-forum/general-discussion/kpti-s-upcoming-asco-presentation
[6] https://meetinglibrary.asco.org/record/186013/abstract
[6] https://youtu.be/xrYoANIeMRc
[6] https://www.globenewswire.com/news-release/2020/05/29/2040910/0/en/Affimed-Highlights-Study-Design-of-its-AFM13-REDIRECT-Trial-at-the-ASCO-2020-Virtual-Meeting.html

Top URLs in Tweet in G5:
[4] https://www.cancerresearch.org/blog/may-2020/asco20-preview-unite-conquer-accelerating-progress
[3] https://www.cancerresearch.org/blog/may-2020/covid-19-impact-blood-cancer-leukemia-lymphoma
[3] https://www.cancerresearch.org/patients/clinical-trials
[3] https://www.npr.org/sections/health-shots/2020/04/11/832210606/coronovirus-pandemic-brings-hundreds-of-u-s-clinical-trials-to-a-halt
[3] https://www.cancerresearch.org/scientists/immuno-oncology-landscape
[3] https://pages.questexnetwork.com/ASCOVirtualSeries-MayJune2020_LandingPage.html
[2] https://eisai.mediaroom.com/2020-05-13-Eisai-to-Present-Latest-Data-from-Oncology-Pipeline-at-ASCO-2020-including-KEYTRUDA-R-pembrolizumab-plus-LENVIMA-R-lenvatinib-Investigational-Combination-Therapy-and-HALAVEN-R-eribulin-mesylate
[2] https://www.cancerresearch.org/news/2020/cancer-cellular-immunotherapies-global-growth
[2] https://meetinglibrary.asco.org/record/185276/abstract
[2] https://meetinglibrary.asco.org/record/189938/abstract

Top URLs in Tweet in G6:
[3] http://nrgoncology.bmetrack.com/c/v?e=1063FE6&c=6B1FD&t=0&l=1F2AF363&email=OIUeEVcwll3OorQD2UPwUj88RYpjfCVcNyIeD9VsXLU%3D
[2] https://twitter.com/ASCO/status/1265251595413000192
[2] https://meetinglibrary.asco.org/results;page=0?filters=JTVCJTdCJTIyZmllbGQlMjIlM0ElMjJNZWRpYVR5cGVzJTIyJTJDJTIydmFsdWUlMjIlM0ElMjJBYnN0cmFjdHMlMjIlMkMlMjJxdWVyeVZhbHVlJTIyJTNBJTIyQWJzdHJhY3RzJTIyJTJDJTIyY2hpbGRyZW4lMjIlM0ElNUIlNUQlN0QlNUQ%3D&meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[2] https://connection.asco.org/magazine/features/breast-cancer-research-foundation-endows-dr-bernard-fisher-memorial-annual?platform=hootsuite
[2] https://twitter.com/ASCO/status/1266393299037958149
[2] https://meetinglibrary.asco.org/record/186922/abstract
[2] https://www.nytimes.com/aponline/2020/05/29/health/bc-us-med-cancer-drugs.html?smid=tw-share
[1] https://twitter.com/DrChowdharyMD/status/1265298715994198026
[1] https://meetinglibrary.asco.org/record/184539/abstract
[1] https://apnews.com/33909708ea62bafe262dad4921363656

Top URLs in Tweet in G7:
[8] https://pacylex.reportablenews.com/pr/pacylex-presents-as-medical-and-investment-conferences-go-virtual
[4] https://www.saluteh24.com/il_weblog_di_antonio/2020/05/mieloma-multiplo-5700-diagnosi-nel-2019-in-italia-9-in-5-anni-asco20.html
[4] https://www.saluteh24.com/il_weblog_di_antonio/2020/05/tumore-del-polmone-piu-sopravvivenza-con-pembrolizumab-e-chemioterapia-asco20.html
[4] https://www.saluteh24.com/il_weblog_di_antonio/2020/05/tumore-del-colon-retto-immunoterapia-in-prima-linea-puo-cambiare-lo-standard-di-cura-asco20.html
[3] https://www.asco.org:443/
[2] https://meetings.asco.org/am/virtual-welcome
[2] https://www.clonoseq.com/technical-summary
[2] https://ir.genocea.com/news-releases/news-release-details/genocea-presents-updated-long-term-safety-immunogenicity-and
[2] https://awesomecapital.blogspot.com/2020/05/adaptimmune-doubles-after-asco20-update.html?spref=tw
[2] http://static1.squarespace.com/sta

Top URLs in Tweet in G8:
[7] https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931187-9%2Ffulltext&rc=0
[4] https://asco20.onlineeventpro.freeman.com/redirect
[2] https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31187-9/fulltext?utm_campaign=trials20&utm_content=130489022&utm_medium=social&utm_source=twitter&hss_channel=tw-27013292
[2] https://www.natera.com/2020asco
[2] https://twitter.com/ASCOPres/status/1265727063144697858
[2] http://www.CONQUER.ORG/Together?utm_content=WeCanVideo&utm_medium=social&utm_campaign=COVIDImpactsCancer&utm_source=twitter
[2] https://meetinglibrary.asco.org/results?meetingView=2020%20ASCO%20Virtual%20Scientific%20Program
[1] https://www.thelancet.com/for-authors?utm_campaign=exhibits19&utm_content=130490352&utm_medium=social&utm_source=twitter&hss_channel=tw-27013292
[1] https://twitter.com/ASCO/status/1250085368508153859
[1] https://www.medscape.com/viewarticle/930881

Top URLs in Tweet in G9:
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa2004407?cookieSet=1
[4] https://twitter.com/fdaoncology/status/1266376336597082112
[3] https://drpicks.carenet.com/d/dpview/news?news_id=12859&ref=63
[2] https://twitter.com/VPrasadMDMPH/status/1264631144378597381
[2] https://meetinglibrary.asco.org/record/186906/abstract
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa2003892?cookieSet=1
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa2004325?cookieSet=1
[2] https://ascopubs.org/doi/abs/10.1200/JCO.20.00793?cookieSet=1
[2] https://ascopubs.org/doi/abs/10.1200/JCO.20.00775?cookieSet=1
[2] https://meetinglibrary.asco.org/record/191877/abstract

Top URLs in Tweet in G10:
[2] https://www.foundationmedicine.com/press-releases/350e49cd-a404-4ba4-a3bf-254dd1d0e690
[1] https://www.bcmafacts.com/
[1] https://www.gene.com/stories/shaping-the-future-of-cancer-care?utm_source=twitter&utm_medium=paid&utm_content=article&utm_campaign=ONC_CRSP_ARTI_ASCO_TW&utm_term=CR&sf122587214=1
[1] https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/investigational-magrolimab-in-combination-with-azacitidine-demonstrates-durable-activity-in-previously-untreated-myelodysplastic-syndrome-and-acute-my
[1] https://www.foundationmedicine.com/press-releases/e9bf4dee-e310-448b-984d-32429d34134c

Top Domains
Top Domains in Tweet in Entire Graph:
[1326] twitter.com
[908] asco.org
[77] ascopubs.org
[68] practiceupdate.com
[66] onclive.com
[58] conquer.org
[50] ascopost.com
[48] ccc19.org
[39] elsevierhealth.com
[36] statnews.com

Top Domains in Tweet in G1:
[781] twitter.com
[273] asco.org
[54] onclive.com
[48] ccc19.org
[39] conquer.org
[36] ascopubs.org
[32] ascopost.com
[29] cancer.net
[22] elsevierhealth.com
[12] symplur.com

Top Domains in Tweet in G2:
[119] asco.org
[65] twitter.com
[23] statnews.com
[15] com.br
[13] targetedonc.com
[10] unicancer.fr
[9] cytomx.com
[7] roche.com
[7] medcitynews.com
[5] conquer.org

Top Domains in Tweet in G3:
[162] asco.org
[162] twitter.com
[57] practiceupdate.com
[13] ascopost.com
[13] medicinematters.com
[11] ascopubs.org
[11] mdanderson.org
[9] onclive.com
[9] nejm.org
[7] elsevierhealth.com

Top Domains in Tweet in G4:
[157] asco.org
[77] twitter.com
[31] 1stoncology.com
[14] evaluate.com
[12] youtube.com
[11] ascopubs.org
[11] trilliumtherapeutics.com
[8] adaptimmune.com
[7] biopharmadive.com
[7] medscape.com

Top Domains in Tweet in G5:
[25] cancerresearch.org
[16] twitter.com
[15] asco.org
[8] healio.com
[5] medifind.com
[4] fiercepharma.com
[3] mediaroom.com
[3] astrazeneca-us.com
[3] npr.org
[3] nature.com

Top Domains in Tweet in G6:
[15] twitter.com
[12] asco.org
[11] dy.si
[5] yalecancercenter.org
[3] bmetrack.com
[2] nytimes.com
[1] apnews.com
[1] ecog-acrin.org
[1] conquer.org
[1] nrgoncology.org

Top Domains in Tweet in G7:
[25] twitter.com
[23] asco.org
[12] linkedin.com
[12] saluteh24.com
[8] reportablenews.com
[4] targetedonc.com
[3] dy.si
[3] cvshealth.com
[3] com.br
[3] healthtalk.no

Top Domains in Tweet in G8:
[8] twitter.com
[7] asco.org
[7] elsevierhealth.com
[4] thelancet.com
[4] freeman.com
[2] natera.com
[2] conquer.org
[1] medscape.com
[1] ascopubs.org
[1] providence.org

Top Domains in Tweet in G9:
[39] twitter.com
[24] asco.org
[11] nejm.org
[5] ascopubs.org
[3] carenet.com
[2] gantaisaku.net
[1] nih.gov
[1] elsevierhealth.com
[1] nature.com
[1] jamanetwork.com

Top Domains in Tweet in G10:
[3] foundationmedicine.com
[1] bcmafacts.com
[1] gene.com
[1] gilead.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[12751] asco20
[701] lcsm
[608] cancer
[479] covid19
[473] oncoalert
[412] askreuters
[404] bcsm
[271] oncology
[219] kidneycancer
[218] lungcancer



Top Hashtags in Tweet in G1:
[5464] asco20
[566] lcsm
[348] askreuters
[312] oncoalert
[291] bcsm
[261] covid19
[247] cancer
[140] ccc19
[138] covid19ncancer
[108] nsclc

Top Hashtags in Tweet in G2:
[1249] asco20
[89] cancer
[41] unicancerasco20
[40] oncologypressroom
[31] covid19
[30] oncology
[25] breastcancer
[19] lcsm
[18] krasg12c
[16] asco2020

Top Hashtags in Tweet in G3:
[2499] asco20
[174] kidneycancer
[141] prostatecancer
[139] bladdercancer
[98] oncoalert
[90] therap
[87] gerionc
[57] cancer
[53] lcsm
[52] covid19

Top Hashtags in Tweet in G4:
[1323] asco20
[103] mmsm
[53] asco20vr
[50] myeloma
[31] sarcoma
[29] cancer
[27] asco2020
[27] lymsm
[26] leusm
[17] lymphoma

Top Hashtags in Tweet in G5:
[214] asco20
[63] lungcancer
[30] askreuters
[13] cancer
[13] lcsm
[10] oncology
[10] clinicaltrials
[6] egfr
[6] bcsm
[5] kidneycancer

Top Hashtags in Tweet in G6:
[199] asco20
[17] lcsm
[16] oncoalert
[12] bloodcancer
[11] radonc
[8] lungcancer
[7] bcsm
[7] cancer
[6] cervicalcancer
[6] radiation

Top Hashtags in Tweet in G7:
[215] asco20
[21] cancer
[14] asco2020
[12] oncology
[9] aml
[8] bio20
[8] bio2020
[5] biotech
[5] mmsm
[4] covid19

Top Hashtags in Tweet in G8:
[100] asco20
[69] cancer
[68] covid19
[12] ccc19
[12] signateralooksdeeper
[12] ctdna
[3] oncoalert
[3] egfr
[3] wecan
[3] conquercancer

Top Hashtags in Tweet in G9:
[270] asco20
[28] asco2020
[26] jcog
[5] lcsm
[5] covid19
[4] cancer
[3] coi
[3] 野良boa
[3] prostatecancer
[3] doctorspicks

Top Hashtags in Tweet in G10:
[106] asco20
[4] realworlddata
[4] brca
[2] mmsm
[2] cancer
[2] liquidbiopsy
[2] lungcancer
[1] breaking

Top Words
Top Words in Tweet in Entire Graph:
[] Top Word Pairs in Tweet in Entire Graph
[] Entire Graph Count
[] Top Word Pairs in Tweet in G1

Top Words in Tweet in G1:
[7819] #asco20
[2099] asco
[1478] cancer
[1376] patients
[1224] #lcsm
[972] #oncoalert
[932] oncoalert
[766] virtual
[712] #askreuters
[682] data

Top Words in Tweet in G2:
[1693] #asco20
[683] asco
[408] virtual
[300] cancer
[298] patients
[222] data
[213] more
[190] meeting
[156] #cancer
[135] t

Top Words in Tweet in G3:
[3993] #asco20
[1358] asco
[667] cancer
[651] trial
[629] patients
[444] 3
[428] vs
[378] t
[359] gt
[358] pts

Top Words in Tweet in G4:
[1739] #asco20
[400] patients
[370] trial
[321] data
[267] study
[267] #mmsm
[261] phase
[242] results
[242] r
[228] cancer

Top Words in Tweet in G5:
[371] #asco20
[142] cancer
[100] patients
[88] stage
[87] learn
[74] s
[67] #askreuters
[64] #lungcancer
[63] 4
[63] 1

Top Words in Tweet in G6:
[255] #asco20
[65] virtual
[59] asco
[55] patients
[52] trial
[45] dr
[44] oral
[43] #oncoalert
[40] meeting
[39] nrg

Top Words in Tweet in G7:
[215] #asco20
[36] virtual
[27] data
[27] more
[25] patients
[22] cancer
[21] meeting
[21] #cancer
[19] new
[18] clinical

Top Words in Tweet in G8:
[222] patients
[195] #asco20
[142] cancer
[116] risk
[116] factors
[79] study
[77] new
[74] covid
[74] 19
[73] #cancer

Top Words in Tweet in G9:
[353] #asco20
[82] patients
[63] drug
[52] cancer
[44] gt
[40] trial
[40] response
[39] study
[39] #jcog
[36] use

Top Words in Tweet in G10:
[138] #asco20
[94] cancer
[83] committed
[75] reimagining
[73] novartis
[73] boldly
[73] blood
[73] disorders
[39] data
[24] s

Top Word Pairs
Top Word Pairs in Tweet in G2:
[507] #asco20,virtual
[501] asco,#asco20
[405] scientific,program
[358] virtual,scientific
[270] lung,cancer
[212] cancer,patients
[208] learn,more
[189] #asco20,asco
[182] featured,voices
[173] follow,twitter

Top Word Pairs in Tweet in G3:
[161] asco,#asco20
[112] #asco20,asco
[97] https,t
[93] t,co
[77] #asco20,abstract
[71] #asco20,virtual
[69] looking,forward
[63] ipi,nivo
[48] #asco20,plenary
[47] ansto,adacap_news

Top Word Pairs in Tweet in G4:
[438] congress,#asco20
[223] r,r
[200] car,t
[200] phase,iii
[147] high,risk
[110] virtual,#asco20
[102] lung,cancer
[96] iii,trial
[94] #mmsm,#asco20
[92] vrd,vs

Top Word Pairs in Tweet in G5:
[196] stage,4
[113] 4,#lungcancer
[102] #lungcancer,diagnosis
[92] diagnosis,came
[92] came,shock
[92] shock,steve
[83] steve,behan
[79] behan,s
[79] s,inspires
[72] inspires,learn

Top Word Pairs in Tweet in G6:
[55] #asco20,virtual
[53] virtual,meeting
[53] oral,abstract
[53] during,#asco20
[53] abstract,session
[53] smilowcancer,yalemed
[53] yalemed,ynhh
[53] #radonc,#oncoalert
[53] present,oral
[53] looking,forward

Top Word Pairs in Tweet in G7:
[33] #asco20,#cancer
[32] #asco2020,#asco20
[25] learn,more
[25] virtual,#asco20
[20] #cancer,#aml
[18] #aml,#bio20
[18] #bio20,#bio2020
[17] annual,meeting
[16] nel,2019
[15] tumore,polmone

Top Word Pairs in Tweet in G8:
[12] patients,cancer
[10] risk,factors
[10] covid,19
[10] clinical,impact
[8] patients,#cancer
[8] 19,patients
[8] cohort,study
[7] #cancer,#covid19
[7] #covid19,30
[7] 30,day

Top Word Pairs in Tweet in G9:
[115] overall,survival
[112] 2nd,gt
[74] #asco20,#asco2020
[58] control,arm
[57] disease,#asco20
[57] approximately,15
[57] 15,20
[56] 20,gastric
[56] gastric,adenocarcinomas
[56] adenocarcinomas,express

Top Word Pairs in Tweet in G10:
[31] reimagining,cancer
[28] novartis,boldly
[26] boldly,committed
[22] committed,reimagining
[22] cancer,blood
[21] blood,disorders
[21] disorders,#asco20
[21] bcmafacts,virtual
[21] virtual,booth
[21] multiple,myeloma

Top Replied-To
Top Replied-To in Entire Graph:
@reuters_health
@narjustdumamd
@asco
@viveksubbiah
@drsgraff
@tmprowell
@glopesmd
@drchoueiri
@n8pennell
@erikahamilton9

Top Replied-To in G1:
@reuters_health
@narjustdumamd
@viveksubbiah
@drsgraff
@asco
@glopesmd
@tmprowell
@apassaromd
@n8pennell
@erikahamilton9

Top Replied-To in G2:
@asco
@jillfeldman4
@jbauml
@narjustdumamd
@sloan_kettering
@dederichleda
@antgiorda
@chadinabhan
@stephenrameymd
@laurajbook

Top Replied-To in G3:
@reuters_health
@montypal
@fabioschutz78
@viveksubbiah
@renohemonc
@danengli
@narjustdumamd
@drchoueiri
@melissaloh21
@asco

Top Replied-To in G4:
@bradloncar
@mtmdphd
@n8pennell
@benwestphalen
@jamienholloway
@vjhemonc
@andybiotech
@jfais20
@eaonc
@agrothey

Top Replied-To in G5:
@slarratt1
@reuters_health
@_im_sg
@asco
@omidhamidmd
@mdandersonnews

Top Replied-To in G6:
@marklewismd
@devikadasmd
@dralexlouie
@dr_tvthomasmd
@narjustdumamd
@ashwinshindemd
@subatomicdoc
@reuters_health
@drchowdharymd
@omidhamidmd

Top Replied-To in G8:
@allanuwanalwis
@jillfeldman4

Top Replied-To in G9:
@hkohko12
@mtcosb
@iamemchee
@m0370

Top Mentioned
Top Mentioned in Entire Graph:
@asco
@oncoalert
@drchoueiri
@conquercancerfd
@montypal
@glopesmd
@narjustdumamd
@tmprowell
@viveksubbiah
@ascopres

Top Mentioned in G1:
@asco
@oncoalert
@glopesmd
@narjustdumamd
@tmprowell
@viveksubbiah
@drsgraff
@conquercancerfd
@drchoueiri
@ascopres

Top Mentioned in G2:
@asco
@oncoalert
@jeanyvesblay
@adamfeuerstein
@groupeunicancer
@prdelord
@amgen
@gustaveroussy
@drenriquegrande
@institut_curie

Top Mentioned in G3:
@asco
@drchoueiri
@oncoalert
@montypal
@pgrivasmdphd
@tompowles1
@rochgerionc
@paulobergerot
@williamdale_md
@neerajaiims

Top Mentioned in G4:
@asco
@myelomamd
@vincentrk
@sagarlonialmd
@eaonc
@mtmdphd
@mdandersonnews
@mohty_ebmt
@mayoclinic
@northtxmsg

Top Mentioned in G5:
@asco
@mdandersonnews
@merck
@cancerresearch
@jenniferlitton
@vmlucey
@astrazeneca
@natrevdrugdisc
@uniofoxford
@drmarkawad

Top Mentioned in G6:
@asco
@yalemed
@nrgonc
@smilowcancer
@ynhh
@yalecancer
@w2ogroup
@barbaraburtness
@rushcancer
@upmchillmancc

Top Mentioned in G7:
@win_consortium
@genoceabio
@tondesignsc

Top Mentioned in G8:
@thelancet
@asco
@ascopres
@conquercancerfd
@covid19nccc
@pashtoonkasi
@sarahtoy17
@peganmalmer
@stevepoltz
@wsj

Top Mentioned in G9:
@nejm
@hildabast
@adamcifu
@asco
@vanitanoronha
@drsidmukherjee
@newyorker
@thewonkologist
@drroyherbstyale
@drchoueiri

Top Mentioned in G10:
@asco
@foundationatcg
@danafarber

Top Tweeters
Top Tweeters in Entire Graph:
@hrblock_21
@threadreaderapp
@isaaranjuez
@teshawnedmonds
@onahunttoday
@paxnostrum
@marketcurrents
@gambiste1
@seekingalpha
@kanekoiroha

Top Tweeters in G1:
@teshawnedmonds
@onahunttoday
@famouspixs
@morgfair
@reuters
@jcmarbury
@michaelorndoff
@africaupdates
@ohiomary
@sharon_lynch

Top Tweeters in G2:
@hrblock_21
@ottlegalrebels
@ronthornton
@craybo23
@govsherazkhan
@wismiss3
@rudyglove27
@cnbc
@hdpr2016
@jjdebenedictis

Top Tweeters in G3:
@threadreaderapp
@le_parisien
@claimcompanies
@9newsaus
@caseofdees
@scieducation1
@pd4ejp
@djkhaled
@urotoday
@swexner

Top Tweeters in G4:
@gambiste1
@seekingalpha
@pfanderson
@omi_082
@yahoofinance
@darylmox
@grandma_hockey
@vane_nicha
@portefeuillefun
@bosepramesh

Top Tweeters in G5:
@paxnostrum
@corruptnsw
@wasregan
@queenpeace2017
@memeburk
@donaldndoro
@northwind1ndn
@suezwillson
@conchi_gonzalez
@wheeliedealer

Top Tweeters in G6:
@adunlea
@ap
@starbucks
@cd_fuller
@sj_pete
@lisalunu
@ponycorraless
@jgfortunato
@aaronstrout
@drericlevi

Top Tweeters in G7:
@marketcurrents
@cmencke
@iconohash
@salutedomani
@healthierit
@cascadia
@antoniocaperna
@healthcarebeat
@gantosj
@bioworld

Top Tweeters in G8:
@isaaranjuez
@galarole08
@saodionisio
@usatoday
@wsj
@nemunokies
@vtaylor9188
@elkequedejoe
@ta7rmpmike
@kmathan

Top Tweeters in G9:
@kanekoiroha
@alizardx
@kimvie
@mesonco
@xiao_signo028
@takumi_0331
@jj_angelus
@pash22
@sr_wiz
@monitor_ph

Top Tweeters in G10:
@john_siracusa
@beverly21811568
@dash_bandy
@mjoehlerich
@orangeorchards
@paulmiller1313
@eecc506
@crystal_night20
@rozsajh
@rosemarie910